¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Amino Acid Multiple Oral"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • tartaric acid
    Ÿ¸£Å¸¸£»ê
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê
  • uric acid
    ¿ä»ê
  • uric acid infarct
    ¿ä»ê°æ»ö
  • uric acid nephropathy
    ¿ä»ê¿°ÄáÆÏº´(Áõ), ¿ä»ê¿°½ÅÀ庴(Áõ)
  • uric acid stone
    ¿ä»êµ¹
  • uridine diphosphate glucuronic acid
    ÀÌÀλê¿ì¸®µò±Û·çÄí·Ð»ê
  • urocanic acid
    ¿ì·ÎÄ­»ê
  • uronic acid
    ¿ì·Ð»ê
  • ursodeoxycholic acid
    ¿ì¸£¼Òµ¥¿Á½ÃÄÝ»ê
  • volatile acid
    Èֹ߼º»ê
  • valproic acid
    ¹ßÇÁ·Î»ê
  • vanillylmandelic acid
    ¹Ù´Ò¸±¸¸µ¨»ê
  • xanthurenic acid
    Å©»êÅõ·»»ê
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • oral hygiene index
    ±¸°­À§»ýÁö¼ö(ÊṲ̀Ëà).
  • oral hypoglycemic agents
    °æ±¸´ç´¢º´¾àÁ¦(ÌèÏ¢ÓØèñÜ»å·ð¥).
  • oral hypoglycemic agents
    °æ±¸´ç´¢º´¾àÁ¦(ÌèÏ¢ÓØèñÜ»å·ð¥).
  • oral immunization
    °æ±¸¸é¿ª(¹ý)(ÌèÏ¢Øóæ¹Ûö).
  • oral immunization
    °æ±¸¸é¿ª(¹ý)(Ë­Ë´ËÎËçËÑ).
  • oral infection
    ±¸°­°¨¿°(Áõ)
  • oral infection
    ±¸°­°¨¿°(Áõ)(Ϣ˷Êïæøñø).
  • oral inoculation
    °æ±¸Åõ¿©
  • oral insulin substitute
    °æ±¸(Àû) ´ë¿ë(ÌèÏ¢îÜÓÛéÄ)Àν¶¸°, °æ±¸(Àû) Àν¶¸° ´ë¿ë¾à(¡­ÓÛéÄå·).
  • oral insulin substitute
    °æ±¸(Àû) ´ë¿ë(ÌèÏ¢(îÜ) ÓÛéÄ)Àν¶¸°, °æ±¸(Àû) Àν¶¸° ´ë¿ë¾à(¡­ÓÛéÄå·).
  • oral intake
    °æ±¸(Àû) ¼·Ãë(ÌèÏ¢îÜàîö¢).
  • oral malignancy
    ±¸³»¾Ç¼ºÁ¾¾ç
  • oral malignancy
    ±¸³»¾Ç¼º Á¾¾ç(Ï¢Ò®ç÷àõðþÜ»).
  • oral manifestation
    ±¸°­Â¡ÈÄ
  • oral manifestation
    ±¸°­Â¡ÈÄ(Ϣ˷ó£ý¦).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • plasmenic acid
    Çö󽺸à»ê(ß«)
  • polyamino acid
    Æú¸®¾Æ¹Ì³ë»ê(ß«)
  • polyenoic fatty acid
    Æú¸®¿¡³ëÀÎ Áö¹æ»ê(ò·Û¸ß«)
  • polyprotic acid
    ´Ù¾ç¼ºÀÚ »ê (ÒýåÕàõí­ß«)
  • polyunsaturated fatty acid
    ´ÙºÒÆ÷È­ Áö¹æ»ê(ÒýÝÕøéûúò·Û¸ß«)
  • prephenic acid
    ÇÁ·¹Ææ»ê(ß«)
  • primary bile acid
    ÀÏÂ÷ ´ãÁó»ê(ìéó­ÓÅñðß«)
  • prostanoic acid
    ÇÁ·Î½ºÅº»ê(ß«)
  • protonic acid
    ÇÁ·ÎÅæ»ê(ß«)
  • pseudouridylic acid
    ½´µµÀ¯¸®µô»ê(ß«)
  • pteroic acid
    Å׷λê(ß«)
  • pteroylglutamic acid
    Å×·ÎÀϱ۷玻ê(ß«)
  • pyroglutamic acid
    ÇǷα۷玻ê(ß«)
  • pyruvic acid
    ÆÄÀÌ·çºê»ê(ß«)
  • reductive carboxylic acid cycle
    ȯ¿ø¼º(ü½êªàõ) Ä«¸£º¹½Ç»ê(ß«) ȸ·Î(üÞÖØ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
IAOM International Association of Oral Myology
KB human oral epidermoid carcinoma cells; Kashin-Bek [disease]; ketone body; kilobyte; Kleihauer-Betke ...
MOPV monovalent oral poliovirus vaccine
OA/BVM oral airway/bag-valve-mask
OAS old age security; oral allergy syndrome; osmotically active substance
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
TOPV Trivalent oral poliovaccine
PO per oral
AMBER Advanced Multiple Beam Equalization Radiography
AcMNPV Autographa californica multiple nuclear polyhedrosis virus
FAMMM Familial atypical multiple mole melanoma
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • serum free fatty acid
    Ç÷û À¯¸® Áö¹æ»ê Á¤·®
    Á¤»óÄ¡´Â Á¶±â °øº¹ ½Ã 200-600¥ìEq/l·Î »ý¸®Àû º¯µ¿ÀÌ Å©´Ù.
  • serum uric acid
    Ç÷û ´¢»ê
    Åëdz, ½ÅºÎÀü, ¹éÇ÷º´ µîÀ¸·Î °í´¢»êÁõÀÌ »ý±ä´Ù.
  • sialic acid
    Ÿ¾×»ê
    ¸¹Àº ¹ÂÄÚ ´Ù´ç·ù¿Í ´çÁöÁú Áß¿¡ Á¸ÀçÇÏ´Â ´º¶ó¹Î»êÀÇ À¯µµÃ¼.
  • silicic acid
    ±Ô»ê
    ±Ô¼Ò¸¦ ¿°±â·Î ÇÏ¿© ±Ô»ê¿°À» Çü¼ºÇÏ´Â °ÍÀ¸·Î ortho ±Ô»ê, meta ±Ô»ê,
  • silicic acid anhydride
    ¹«¼ö ±Ô»ê
  • silicotungstic acid
    ½Ç¸®ÄÚ ÅÖ½ºÅÙ»ê
    ¹é»ö ¶Ç´Â Ȳ»öÀÇ °áÁ¤. ¾ËÄ®·ÎÀÌµå ½Ã¾àÀ¸·Î ¾²ÀδÙ.
  • sorbic acid
    ¼Ò¸£ºó»ê
    sorbus aucu
  • sugar acid
    ´ç»ê
  • sulfuric acid
    Ȳ»ê
    ¹Ðµµ°¡ ³ô°í ±â¸§°ú °°ÀÌ º¸ÀÌ´Â ¾×üÀÇ »êÀε¥ ¼ö¼Ò, À¯È², »ê¼Ò·Î ±¸¼ºµÇ¾úÀ¸¸ç Ä¡°ú ±â°ø¿¡¼­´Â µ¿·®ÀÇ ¹°°ú È¥ÇÕÇÏ¿© ÁÖÁ¶¹° ¼¼Ã´ ¿ë¾×À¸·Î »ç¿ëÇÑ´Ù.
  • tartaric acid
    Ÿ¸£Å¸¸£»ê, ÁÖ¼®»ê
    Æ÷µµÁÖÀÇ Â±â¿Í ¿©·¯ ½Ä¹°·ÎºÎÅÍ ¾ò´Â ¹é»ö ºÐ¸». 4°¡Áö ÇüÅ·Π¾Ë·ÁÁ® ÀÖ´Ù.
  • titratable acid

    titrate (ÀûÁ¤ÇÏ´Ù

  • total acid phosphatase
    Ãѻ꼺 ÀÎ»ê ºÐÇØ È¿¼Ò, Ãѻ꼺 Æ÷½ºÆÄŸÁ¦
  • ulmic acid
    ¿ï¹Î»ê
    ´À¸¨³ª¹« Áó¿¡¼­ ¾ò¾îÁö´Â À¯±â»ê.
  • umbellic acid
    ¿òº§»ê
  • unesterified fatty acid
    ºñ¿¡½ºÅ׸£È­ Áö¹æ»ê
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
activated carboxylic acid Derivative of a carboxyl group that is more susceptible to nucleophilic attack than a free carboxyl group; e.g., acid anhydrides, thioesters.
(05 Mar 2000)
activated fatty acid A fatty acyl-coenzyme A thiol ester.
(05 Mar 2000)
acyclic acid <chemistry> Carboxylic acids that have open-chain molecular structures as opposed to ring-shaped structures.
(25 Jun 1999)
acyl-CoA-6-aminopenicillanic acid acyltransferase <enzyme> Acyl CoA and aminopenicillanic acid yield penicillin and CoA
Registry number: EC 2.3.1.-
Synonym: 6-apa acyltransferase, 6-aminopenicillanic acid-phenacetyl-CoA-phenoxyacetyl-CoA transferase, acyl-coenzyme a-6-aminopenicillanic acid acyltransferase, isopenicillin n-phenylacetyl-CoA acyltransferase, penicillin acyltransferase, isopenicillin n-phenylacetyl-coenzyme a acyltransferase, acyl-CoA-ipn acyltransferase, isopenicillin n acyltransferase, aat gene product, pende gene product
(26 Jun 1999)
acyl glutamic acid amidohydrolase <enzyme> Specific for long chain acyl groups such as lauroyl, myristoyl and palmitoyl
Registry number: EC 3.5.1.-
(26 Jun 1999)
adenylic acid A condensation product of adenosine and phosphoric acid; a nucleotide found among the hydrolysis products of all nucleic acids. 3'-Adenylic acid (adenosine 3'-monophosphate) and 5'-adenylic acid (adenosine 5'-monophosphate) differ in the place of attachment of the phosphoric acid to the d-ribose; deoxyadenylic acid differs in having H instead of OH at the 2' position of d-ribose.
See: AMP.
Synonym: adenine nucleotide.
(05 Mar 2000)
adenylic acid deaminase <enzyme> An enzyme that catalyses the deamination of AMP to imp.
Chemical name: AMP aminohydrolase
Registry number: EC 3.5.4.6
(12 Dec 1998)
adenylic acid kinase <enzyme> An enzyme that catalyses the phosphorylation of AMP to ADP in the presence of ATP or inorganic triphosphate.
Chemical name: ATP:AMP phosphotransferase
Registry number: EC 2.7.4.3
(12 Dec 1998)
adenylosuccinic acid A condensation product of aspartic acid and inosine 5'-monophosphate; an intermediate in the biosynthesis of adenylic acid. Formally, it is adenylic acid with succinic acid replacing an H of the NH2 group, forming a C-N.
Synonym: adenylylosuccinic acid, N-succinyladenylic acid.
Acronym: sAMP
(05 Mar 2000)
adenylylosuccinic acid A condensation product of aspartic acid and inosine 5'-monophosphate; an intermediate in the biosynthesis of adenylic acid. Formally, it is adenylic acid with succinic acid replacing an H of the NH2 group, forming a C-N.
Synonym: adenylylosuccinic acid, N-succinyladenylic acid.
Acronym: sAMP
(05 Mar 2000)
adipic acid Hexanedioic acid;the dicarboxylic acid, HOOC(CH2)4COOH.
(05 Mar 2000)
agaric acid Alpha-Hexadecylcitric acid; 2-hydroxy-1,2,3-nonadecanetricarboxylic acid;obtained from agaric and responsible for the anhidrotic action of the mushroom; used as an anhidrotic agent.
Synonym: agaricic acid, agaricinic acid.
(05 Mar 2000)
agaricic acid Alpha-Hexadecylcitric acid; 2-hydroxy-1,2,3-nonadecanetricarboxylic acid;obtained from agaric and responsible for the anhidrotic action of the mushroom; used as an anhidrotic agent.
Synonym: agaricic acid, agaricinic acid.
(05 Mar 2000)
agaricinic acid Alpha-Hexadecylcitric acid; 2-hydroxy-1,2,3-nonadecanetricarboxylic acid;obtained from agaric and responsible for the anhidrotic action of the mushroom; used as an anhidrotic agent.
Synonym: agaricic acid, agaricinic acid.
(05 Mar 2000)
aklanonic acid methyl ester cyclase <enzyme> Catalyses the formation of aklaviketone from aklanonic acid methyl ester; involved in daunomycin biosynthesis; see also daunorubicin-doxorubicin polyketide synthase
Registry number: EC 5.-
Synonym: aame cyclase, daud protein, daud gene product, dnrd protein, dnrd gene product
(26 Jun 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 19
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 19
ÅëÇÕ°Ë»ö ¿Ï·á